4.8 Review

Glutamine and cancer: cell biology, physiology, and clinical opportunities

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 9, Pages 3678-3684

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI69600

Keywords

-

Funding

  1. NIH [5T32GM007062-38, 1R01CA157996-02]
  2. Children's Cancer Fund
  3. Damon-Runyon Cancer Research Foundation
  4. Welch Foundation [I-1733]

Ask authors/readers for more resources

Glutamine is an abundant and versatile nutrient that participates in energy formation, redox homeostasis, macromolecular synthesis, and signaling in cancer cells. These characteristics make glutamine metabolism an appealing target for new clinical strategies to detect, monitor, and treat cancer. Here we review the metabolic functions of glutamine as a super nutrient and the surprising roles of glutamine in supporting the biological hallmarks of malignancy. We also review recent efforts in imaging and therapeutics to exploit tumor cell glutamine dependence, discuss some of the challenges in this arena, and suggest a disease-focused paradigm to deploy these emerging approaches.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available